In addition, a recent in silico molecular docking study regarding the DPP4/CTNNB1/MET signatures showed that stagliptin could be a potential TC drug, however more investigations are surely needed to confirm it ( Gemigliptin Gemigliptin is an orally bioavailable inhibitor of DPP-4, with hypoglycemic and potential renoprotective activities
Patients experiencing chronic fatigue, neurological disorders, cardiovascular issues, or symptoms of heavy metal toxicity benefit from this treatment
Rukavina Mikusic NL, Kouyoumdzian NM, Choi MR (2020) Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis
For vitamin D, as an example, the AI (RDA) in Japan is only 8.5 g/day (340 IU/day) for adults, whereas in the US the RDA is 600 IU
Liew CF, Wise SD, Yeo KP, Lee KO